SweetValueLab
Write for us

American Tower vs Crown Castle AMT vs CCI

American Tower and Crown Castle on one sheet: valuation multiples, growth, margins, debt, dividends and returns, each section labelled with the period it covers, from the companies' filings. Add or remove a stock above the sheet; the link holds the set.

Compare other stocks
AMTCCI

What differs most

generated from the numbers below
  • Consensus revenue growth for next year: Crown Castle +1778.8%, American Tower +1078.1%.
  • Market value: American Tower $86.33B, Crown Castle $35.95B.
  • Price / sales: Crown Castle 177.1×, American Tower 96.6×.
  • Free-cash-flow yield: Crown Castle 8.0%, American Tower 4.4%.

Price return

2025-10-16 → 2026-10-16
AMT−3.2%
CCI−16.1%
-40%-30%-20%-10%0%10%2025-10-162026-04-172026-10-16
Prices at the close on 2026-10-16

Profile

latest
Sector
Real Estate
Real Estate
Industry
REIT - Specialty
REIT - Specialty
Market value
$86.33B
$35.95B
Enterprise value
$121.76B
$53.14B
Employees
4,866
1,500
Revenue per employee (TTM)
$184K
$135K

Our models

nightlythe valuation on each stock's page
Price vs model
19% undervalued vs model
3% undervalued vs model
Model range
$197–245
$78.67–98.51
Models in the headline
1
1
FCF growth priced in, at a 10% return
18.4%
10.3%
Every model, its assumptions and its range: AMT valuation · CCI valuation. The growth priced in, at any return: AMT reverse DCF · CCI reverse DCF.

Trading

close 2026-10-16
Last close
$185.27
$82.26
52-week high
$194.12
$98.87
52-week low
$161.06
$66.12
Price vs 52-week high
−4.6%
−16.8%
Price vs 52-week low
+15.0%
+24.4%
Average daily volume / shares
0.6%
0.9%
Beta
0.89
0.96

Returns

to 2026-10-16
1 month
+5.0%
+12.3%
3 months
+9.7%
+4.5%
6 months
+3.7%
−5.3%
Year to date
+5.5%
−7.4%
1 year
−3.2%
−16.1%
1 year, dividends added
+0.5%
−11.8%
2 years
−18.6%
−28.9%

Valuation

price × TTM to Jun 2026
P/E (TTM)
25.4×
41.8×
P/E on consensus EPS (next FY)
26.6×
42.8×
Price / sales
96.6×
177.1×
EV / sales
136.3×
261.8×
EV / EBITDA
17.5×
19.9×
Price / book
23.2×
—
Price / free cash flow (FY)
22.8×
12.5×
Free-cash-flow yield (FY)
4.4%
8.0%

Growth

TTM and FY2025
Revenue growth (TTM)
—
—
Revenue growth, consensus next FY
+1078.1%
+1778.8%
Revenue, 3-year CAGR
3.1%
−32.4%
Revenue, 5-year CAGR
13.6%
−16.2%
EPS growth (TTM)
—
—
EPS growth, consensus next FY
+29.1%
+90.3%
EPS, 3-year CAGR
12.2%
−36.0%
Free cash flow, 3-year CAGR
27.6%
22.4%
Diluted shares, 3-year change
+1.3%
+0.7%

Profitability

TTM to Jun 2026
Gross margin (FY)†
73.7%
66.1%
Operating margin
548.7%
976.8%
EBITDA margin
780.5%
1312.3%
Net margin
393.5%
424.6%
Free-cash-flow margin (FY)
404.3%
1337.2%
Return on equity
94.5%
—
Return on assets
5.6%
4.0%
Asset turnover
0.01
0.01
† Gross margin (FY): As filed. Companies draw the cost-of-revenue line in different places, so gross margins of two companies in one industry can differ for that reason alone; operating margin does not depend on where the line is drawn.

Balance sheet

MRQ Jun 2026
Cash
$1.76B
$1.04B
Total debt
$37.19B
$18.24B
Net debt
$35.43B
$17.20B
Debt / equity
10.0×
—
Net debt / EBITDA (TTM)
5.1×
6.5×
Interest coverage (FY)
4.8×
2.2×
Current ratio (FY)
0.63
0.26

Dividends

trailing 12 months
Dividend yield
3.8%
5.2%
Dividends per share
$7.07
$4.25
Payout ratio (of TTM EPS)
97.1%
215.7%
Dividend per share, 5-year CAGR
7.0%
−4.4%
Frequency
Quarterly
Quarterly

Ownership and activity

last 90 days · latest 13F
Tracked superinvestors holding (13F)
4
0
Insider open-market buys (Form 4)
$501K
$0
Insider sales (Form 4)
$1.2M
$114K
Analyst upgrades
1
1
Analyst downgrades
0
1

Statements

income TTM to Jun 2026 · cash flow FY2025
Revenue
$893.4M
$203.0M
EBITDA
$6.97B
$2.66B
Operating income
$4.90B
$1.98B
Net income
$3.52B
$862.0M
EPS (diluted)
$7.28
$1.97
Operating cash flow
$5.46B
$3.06B
Capital expenditure
−$1.68B
−$182.0M
Free cash flow
$3.78B
$2.88B
Dividends paid
$3.18B
$2.08B

Keep comparing

the matchups people search for

Statements from the companies' SEC filings; prices, dividends and consensus estimates from Financial Modeling Prep; insider trades from Form 4 and holdings from 13F. Refreshed nightly. A comparison of filed numbers, not a recommendation to buy, sell or hold any security.